Changes in serotype distribution may hamper efficacy of pneumococcal conjugate vaccines in children

Scandinavian Journal of Infectious Diseases

Volumn 33, Issue 11, 2001, Pages 848-850

  Normark, B H ^a   Ortqvist A ^a   Kalin, M ^a   Olsson Liljequist, B ^a   Hedlund, J ^a   Svenson, S B ^a   Kallenius G ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CHILD; CONJUGATION; CONTROLLED STUDY; DRUG EFFICACY; HEALTH PROGRAM; HUMAN; INCIDENCE; INFANT; LABORATORY; MAJOR CLINICAL STUDY; SEROTYPE; STREPTOCOCCUS PNEUMONIA; SWEDEN; TIME; VACCINATION;

EID: 0035175559     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/713933757     Document Type: Article

References (16)

1. Antibiotic resistance in Streptococcus pneumoniae
2. Pneumococcal disease and the role of conjugate vaccines
3. Pneumococcal vaccines: History, current status, and future directions
4. Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden
5. Serotypes and resistance patterns of Streptococcus pneumoniae causing systemic disease in Northern Norway
6. Incidence of invasive pneumococcal disease and distribution of capsular types in Denmark, 1989-94
7. The use of precipitin analysis in agar for the study of human streptococcal infections. II. Ouchterlony and Oakley technics
8. Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae
9. Six newly recognized types of Streptococcus penumoniae
10. Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing
11. Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries
12. The clinical significance of pneumococcal serotypes
13. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae Alaska, 1991-1998
14. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines
15. Preparation of pneumococcal capsular polysaccharide-protein conjugate vaccines utilizing new fragmentation and conjugation technologies